Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07356570

Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Conditions

Interventions

TypeNameDescription
OTHERBlood sample collectionA one-time 30 mL blood draw is performed during the inclusion visit for immunological and molecular analysis as part of the HERVCOV research program. No therapeutic intervention is administered, and no samples are stored after analysis.

Timeline

Start date
2025-06-13
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2026-01-21
Last updated
2026-01-21

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07356570. Inclusion in this directory is not an endorsement.

Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Coh (NCT07356570) · Clinical Trials Directory